Contrave

News

Why Estimates of Future Revenues for Obesity Drugs Are Likely Off the Mark

BNET Pharma

»

Login or register to post comments

News

Cramer Likes Orexigen: Should You?

Seeking Alpha

»

Login or register to post comments

News

Orexigen Therapeutics is “all about the FDA” right now

CNBC

»

Login or register to post comments

News

Orexigen obesity drug meets goals in 3 studies

Yahoo/AP

»

Login or register to post comments

News

Orexigen licenses obesity drug-related patents

Yahoo/AP

»

Login or register to post comments

News

Orexigen's Contrave: Generic Would Be No Cheaper

Seeking Alpha

»

Login or register to post comments

News

Arena, The Aftermath

Seeking Alpha

»

Login or register to post comments

News

Three Ways to Play Arena Pharmaceuticals

Seeking Alpha

»

Login or register to post comments

News

Take Advantage of Market Confusion to Buy Orexigen Therapeutics

Seeking Alpha

»

Login or register to post comments

News

Arena Pharmaceuticals: Near Term Gamble May Be Worth It

Seeking Alpha

»

Login or register to post comments